Vous êtes ici: Home I Produits I Camomille (fleurs) extrait CO2-to, intégré Product-No.: 019.001

Camomille (fleurs) extrait CO2-to, intégré
Product-No.: 019.001

Autres documents relatifs au produit sont disponibles sur demande

Matières Premières:
Chamomilla recutita – Flowers, dried, from controlled integrated cultivation

Fabrication:
By supercritical fluid extraction with natural carbon dioxide, no inorganic salts, no solvent residues, no heavy metals, no reproducible microorganisms [1].

Ingrédients:
The extract contains 10 – 20 % essential oil, mainly consisting of 20 – 45 % alpha-bisabolol, 5 – 20 % bisabolol oxides, farnesene, chamazulene, cis- and trans-en-yn-dicycloether and spathulenol. The content of matricin in the extract is 0.5 – 2.5 % (analysed via chamazulene). The extract also contains fat and waxes as well as small amounts of herniarine.

Utilisation:
Camomile extract is used in herbal medicinal products for internal use in gastrointestinal diseases, external use in the treatment of inflammation of the skin and mucous membranes, inflammatory diseases of the respiratory system or diseases of the anal and genital area [2].*

For the flavouring of food, e.g. beverages, sweets.*

Because of its digestible and beneficial properties, chamomile is also suitable for use in food supplements.*

Due to its anti-inflammatory and deodorizing properties, chamomile extract can be used as an additive in cleansing and care products such as skin creams, body lotions, soaps, deodorants and in oral care products. The extract is also suitable as a fragrance in perfumes or other cosmetic products [3].*

Littérature:
[1] P. Manninen, E. Häivälä, S. Sarimo, H. Kallio : Distribution of microbes in supercritical CO2 extraction of sea buckthorn (Hippophae rhamnoides) oils : Zeitschrift für Lebensmitteluntersuchung und -Forschung / Springerverlag (1997) 204: 202-205
[2] Wolfgang Blascheck u.a. (Hrsg.) : HagerROM 2017, Hagers Enzyklopädie der Arzneistoffe und Drogen : Suttgart: Wissenschaftliche Verlagsgesellschaft Stuttgart, 2017
[3] F.C. Czygan, D. Frohne, Chr. Höltzel, A. Nagell, P. Pachaöy, H.J. Pfänder, M. Wichtl, g. Willhuhn, W. Buff : Teedrogen und Phytopharmaka, 3. Auflage. : Stuttgart: Wissenschaftliche Verlagsgesellschaft GmbH 1997

* Statements summarise literature evidence and have informative character. They might be derived from in vitro or animal tests and thus not be substantiated for humans. Statements have not been evaluated by competent authorities and do not refer to finished products. The marketer of any finished product containing any FLAVEX extract as ingredient is responsible for assuring that the claims made for his product are lawful and comply with all applicable laws and regulations of the country in which the product is to be sold.